Developing predictive assays: The phenotypic screening “rule of 3”

Fabien Vincent, Paula M. Loria, Marko J. Pregel et al. · Science Translational Medicine · 2015

Phenotypic drug discovery approaches can positively affect the translation of preclinical findings to patients. However, not all phenotypic assays are created equal. A critical question then follows: What are the characteristics of the optimal assays? We analyze this question and propose three specific criteria related to the disease relevance of the assay-system, stimulus, and end point-to help design the most predictive phenotypic assays.

Cited by 199 works. doi:10.1126/scitranslmed.aab1201

Authors

References